Study an microbial persistence in end-stage idiopathic dilated cardiomyopathy

被引:13
|
作者
de Leeuw, N
Melchers, WJG
Balk, AHMM
de Jonge, N
Galama, JMD
机构
[1] Univ Nijmegen Hosp, Dept Med Microbiol, NL-6500 HB Nijmegen, Netherlands
[2] Univ Hosp Rotterdam Dijkzigt, Dept Cardiol, Rotterdam, Netherlands
[3] Univ Utrecht Hosp, Dept Cardiol, Utrecht, Netherlands
关键词
D O I
10.1086/598625
中图分类号
R392 [医学免疫学]; Q939.91 [免疫学];
学科分类号
100102 ;
摘要
Microbial persistence may be involved in the pathogenesis of idiopathic dilated cardiomyopathy (IDC). Therefore, we evaluated the role of various cardiopathogenic microorganisms in patients with end-stage IDC. In a previous study, we did not find evidence for the persistence of enterovirus RNA in end-stage IDC. In the present study, we looked for other microorganisms that are frequently associated with heart disease, including cytomegalovirus, hepatitis B virus,hepatitis C virus, Borrelia burgdorferi, Chlamydia species, mycoplasmata, and Toxoplasma gondii. Serology, polymerase chain reaction (PCR) analysis specific for detection of microbial genomic sequences, or both investigations were performed on myocardial samples from 37 patients with end-stage IDC. PCR analysis was performed on multiple myocardial samples per patient Thirty-nine patients with end-stage heart disease of known cause were included as controls. On the basis of our serological data and PCR analyses, we did not find any evidence that microbial persistence in the heart is involved in the end-stage disease process of IDC.
引用
收藏
页码:522 / 525
页数:4
相关论文
共 50 条
  • [31] Detection of enteroviral RNA in end-stage dilated cardiomyopathy in children and adolescents
    Arola, A
    Kallajoki, M
    Ruuskanen, O
    Hyypia, T
    JOURNAL OF MEDICAL VIROLOGY, 1998, 56 (04) : 364 - 371
  • [32] Effects of permanent dual chamber pacing in end-stage dilated cardiomyopathy
    Brecker, SJD
    Kelly, PA
    Chua, TP
    Gibson, DG
    HEART, 1996, 75 (05) : 46 - 46
  • [33] Transcriptome profiling of natriuretic peptide system in cardiac tissue of patients with idiopathic or ischemic end-stage dilated cardiomyopathy
    Cabiati, M.
    Svezia, B.
    Cesare, M. M.
    Botta, L.
    Caselli, C.
    Matteucci, M.
    Lionetti, V.
    Del Ry, S.
    VASCULAR PHARMACOLOGY, 2015, 75 : 43 - 43
  • [34] Increased myocyte calcium sensitivity in end-stage pediatric dilated cardiomyopathy
    Nakano, Stephanie J.
    Walker, John S.
    Walker, Lori A.
    Li, Xiaotao
    Du, Yanmei
    Miyamoto, Shelley D.
    Sucharov, Carmen C.
    Garcia, Anastacia M.
    Mitchell, Max B.
    Ambardekar, Amrut, V
    Stauffer, Brian L.
    AMERICAN JOURNAL OF PHYSIOLOGY-HEART AND CIRCULATORY PHYSIOLOGY, 2019, 317 (06): : H1221 - H1230
  • [35] ANIMAL MODEL FOR UNLOADING THE RAT HEARTS OF END-STAGE DILATED CARDIOMYOPATHY
    Meng Zili
    Li Hongwei
    Li Qiang
    HEART, 2013, 99 : E53 - E53
  • [36] Genotype influences end-stage heart failure occurrence in dilated cardiomyopathy
    Cannie, D.
    Bakalakos, A.
    Protonotarios, A.
    Syrris, P.
    Lorenzini, M.
    Guttmann, O.
    O'mahony, C.
    Savvatis, K.
    Lopes, L.
    Sekhri, N.
    Mohiddin, S.
    Elliott, P.
    EUROPEAN HEART JOURNAL, 2023, 44
  • [37] Partial Left Ventriculectomy for End-Stage Dilated Cardiomyopathy in Small Children
    Kubota, Suguru
    Matsui, Yoshiro
    CIRCULATION JOURNAL, 2009, 73 (06) : 1010 - 1011
  • [38] DISCREPANCY BETWEEN PRETRANSPLANT AND POSTTRANSPLANT DIAGNOSIS OF END-STAGE DILATED CARDIOMYOPATHY
    BORTMAN, G
    SELLANES, M
    ODELL, DS
    RING, WS
    OLIVARI, MT
    AMERICAN JOURNAL OF CARDIOLOGY, 1994, 74 (09): : 921 - 924
  • [39] Transcriptome profiling of natriuretic peptide system in cardiac tissue of patients with idiopathic or ischemic end-stage dilated cardiomyopathy
    Cabiati, M.
    Svezia, B.
    Cesare, M. M.
    Botta, L.
    Caselli, C.
    Matteucci, M.
    Lionetti, V.
    Del Ry, S.
    EUROPEAN HEART JOURNAL, 2015, 36 : 153 - 153
  • [40] Reverse left ventricular remodeling by dobutamine and amiodarone in end-stage heart failure due to idiopathic dilated cardiomyopathy
    Maroulidis, G
    Alexopoulos, G
    Ntalianis, A
    Drakos, S
    Venetsanakos, J
    Christodoulou, K
    Kopelia, M
    Sarafoglou, S
    Savvari, V
    Anastasiou-Nana, M
    JOURNAL OF CARDIAC FAILURE, 2005, 11 (06) : S158 - S158